CoChat

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

Arieta, Christina M., Xie, Yushu Joy, Rothenberg, Daniel A., Diao, Huitian, Harjanto, Dewi, Meda, Shirisha, Marquart, Krisann, Koenitzer, Byron, Sciuto, Tracey E., Lobo, Alexander, Zuiani, Adam, Krumm, Stefanie A., Cadima Couto, Carla Iris, Hein, Stephanie, Heinen, André P., Ziegenhals, Thomas, Liu-Lupo, Yunpeng, Vogel, Annette B., Srouji, John R., Fesser, Stephanie, Thanki, Kaushik, Walzer, Kerstin, Addona, Theresa A., Türeci, Özlem, Şahin, Uğur, Gaynor, Richard B., Poran, Asaf · 2023 · Cell
Cited by 91

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2023.04.007

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 67

  1. Cao, 2023, Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution, Nature, 614, 521
  2. Jian, 2022, Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, Lancet Infect. Dis., 22, 1535, 10.1016/S1473-3099(22)00642-9 · DOI
  3. Kurhade, 2022, Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine, Nat. Commun., 13, 3602, 10.1038/s41467-022-30681-1 · DOI
  4. Muik, A., Lui, B.G., Diao, H., Fu, Y., Bacher, M., Toker, A., Grosser, J., Ozhelvaci, O., Grikscheit, K., Hoehl, S., et al. (2022). Progressive Loss of Conserved Spike Protein Neutralizing Antibody Sites in Omicron Sublineages Is Balanced by Preserved T-Cell Recognition Epitopes. bioRxiv, 2022.2012.2015.520569. 10.1101/2022.12.15.520569 · DOI
  5. Wherry, 2022, T cell immunity to COVID-19 vaccines, Science, 377, 821, 10.1126/science.add2897 · DOI · Paper page
  6. Guerrera, 2021, BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype, Sci. Immunol., 6, 10.1126/sciimmunol.abl5344 · DOI · Paper page
  7. Hurme, 2022, Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients, Front. Immunol., 13, 10.3389/fimmu.2022.869990 · DOI
  8. Koutsakos, 2023, SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses, Immunity, 56, 879, 10.1016/j.immuni.2023.02.017 · DOI
  9. Neale, 2023, CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study, medRxiv
  10. Kent, 2022, Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?, Nat. Rev. Immunol., 22, 387, 10.1038/s41577-022-00716-1 · DOI · Paper page
  11. Schulien, 2021, Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells, Nat. Med., 27, 78, 10.1038/s41591-020-01143-2 · DOI · Paper page
  12. Kalimuddin, 2021, Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset, Med (N Y), 2, 682
  13. Matchett, 2021, Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity, J. Immunol., 207, 376, 10.4049/jimmunol.2100421 · DOI · Paper page
  14. Carter, 2023, A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta, Front. Immunol., 14, 10.3389/fimmu.2023.1135815 · DOI · Paper page
  15. Swadling, 2022, Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2, Nature, 601, 110, 10.1038/s41586-021-04186-8 · DOI · Paper page
  16. Foix, 2022, Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2, PLoS Comput. Biol., 18, 10.1371/journal.pcbi.1009726 · DOI
  17. Gauttier, 2020, Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine, bioRxiv
  18. Poran, 2020, Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes, Genome Med., 12, 70, 10.1186/s13073-020-00767-w · DOI · Paper page
  19. Bezstarosti, 2021, Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens, PLoS One, 16, 10.1371/journal.pone.0259165 · DOI
  20. Bouhaddou, 2020, The Global Phosphorylation Landscape of SARS-CoV-2 Infection, Cell, 182, 685, 10.1016/j.cell.2020.06.034 · DOI · Paper page
  21. Perlman, 2009, Coronaviruses post-SARS: update on replication and pathogenesis, Nat. Rev. Microbiol., 7, 439, 10.1038/nrmicro2147 · DOI · Paper page
  22. Abelin, 2019, Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction, Immunity, 51, 766, 10.1016/j.immuni.2019.08.012 · DOI · Paper page
  23. Choi, 2021, Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations, Cell Rep. Methods, 1
  24. Francis, 2022, Allelic variation in class I HLA determines CD8(+) T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2, Sci. Immunol., 7
  25. Kared, 2021, SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals, J. Clin. Invest., 131, 10.1172/JCI145476 · DOI · Paper page
  26. Saini, 2021, SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients, Sci. Immunol., 6, 10.1126/sciimmunol.abf7550 · DOI · Paper page
  27. Kyte, 1982, A simple method for displaying the hydropathic character of a protein, J. Mol. Biol., 157, 105, 10.1016/0022-2836(82)90515-0 · DOI · Paper page
  28. Vitiello, 1991, Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex, J. Exp. Med., 173, 1007, 10.1084/jem.173.4.1007 · DOI · Paper page
  29. Sturm, 2020, Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data, Bioinformatics, 36, 4817, 10.1093/bioinformatics/btaa611 · DOI · Paper page
  30. Twohig, 2022, Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study, Lancet Infect. Dis., 22, 35, 10.1016/S1473-3099(21)00475-8 · DOI · Paper page
  31. Storm, N., Crossland, N.A., McKay, L.G.A., and Griffiths, A. (2022). Comparative Infection and Pathogenesis of SARS-CoV-2 Omicron and Delta Variants in Aged and Young Syrian Hamsters. bioRxiv, 2022.2003.2002.482662. 10.1101/2022.03.02.482662 · DOI
  32. Li, 2022, Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant, Nat. Commun., 13, 460, 10.1038/s41467-022-28089-y · DOI · Paper page
  33. Abelin, 2017, Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction, Immunity, 46, 315, 10.1016/j.immuni.2017.02.007 · DOI · Paper page
  34. Schubert, 2016, Designing string-of-beads vaccines with optimal spacers, Genome Med., 8, 9, 10.1186/s13073-016-0263-6 · DOI
  35. Ali, 2019, Induction of neoantigen-reactive T cells from healthy donors, Nat. Protoc., 14, 1926, 10.1038/s41596-019-0170-6 · DOI
  36. Shou, 2021, Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates, Front. Microbiol., 12, 10.3389/fmicb.2021.626553 · DOI
  37. Wellford, 2022, Mucosal plasma cells are required to protect the upper airway and brain from infection, Immunity, 55, 2118, 10.1016/j.immuni.2022.08.017 · DOI
  38. Suzuki, 2022, Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant, Nature, 603, 700, 10.1038/s41586-022-04462-1 · DOI · Paper page
  39. Hakki, 2022, Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study, Lancet Respir. Med., 10, 1061, 10.1016/S2213-2600(22)00226-0 · DOI
  40. Jones, 2021, Estimating infectiousness throughout SARS-CoV-2 infection course, Science, 373, eabi5273, 10.1126/science.abi5273 · DOI · Paper page
  41. Tang, 2021, BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar, Nat. Med., 27, 2136, 10.1038/s41591-021-01583-4 · DOI · Paper page
  42. Chandrashekar, 2021, Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants, Sci. Transl. Med., 13, 10.1126/scitranslmed.abj2641 · DOI
  43. Angyal, 2022, T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study, Lancet. Microbe, 3, e21, 10.1016/S2666-5247(21)00275-5 · DOI · Paper page
  44. Munoz-Fontela, 2022, Advances and gaps in SARS-CoV-2 infection models, PLoS Pathog., 18, 10.1371/journal.ppat.1010161 · DOI · Paper page
  45. Dong, 2022, The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus, J. Virol., 96, 10.1128/JVI.00964-21 · DOI · Paper page
  46. Valyi-Nagy, 2021, Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans, Geroscience, 43, 2321, 10.1007/s11357-021-00471-6 · DOI
  47. Brademan, 2019, Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications, Mol. Cell. Proteomics, 18, 10.1074/mcp.TIR118.001209 · DOI · Paper page
  48. Kreiter, 2008, Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals, J. Immunol., 180, 309, 10.4049/jimmunol.180.1.309 · DOI · Paper page
  49. Bilich, 2021, T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals, Sci. Transl. Med., 13, eabf7517, 10.1126/scitranslmed.abf7517 · DOI · Paper page
  50. Habel, 2020, Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A∗02:01 phenotype, Proc. Natl. Acad. Sci. USA, 117, 24384, 10.1073/pnas.2015486117 · DOI · Paper page
  51. Hu, 2022, Identification of cross-reactive CD8(+) T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants, Genes Dis., 9, 216, 10.1016/j.gendis.2021.05.006 · DOI
  52. Joag, 2021, Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses, J. Immunol., 206, 931, 10.4049/jimmunol.2001400 · DOI
  53. Lee, 2021, Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity, J. Virol., 95, 10.1128/JVI.02002-20 · DOI
  54. Lineburg, 2021, CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses, Immunity, 54, 1055, 10.1016/j.immuni.2021.04.006 · DOI · Paper page
  55. Liu, 2010, The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes, J. Infect. Dis., 202, 1171, 10.1086/656315 · DOI · Paper page
  56. Nagler, 2021, Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics, Cell Rep., 35, 10.1016/j.celrep.2021.109305 · DOI · Paper page
  57. Nguyen, 2021, CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity, Immunity, 54, 1066, 10.1016/j.immuni.2021.04.009 · DOI
  58. Nielsen, 2021, SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity, EBioMedicine, 68, 10.1016/j.ebiom.2021.103410 · DOI
  59. Obermair, 2022, High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape, Sci. Adv., 8, 10.1126/sciadv.abl5394 · DOI
  60. Rha, 2021, PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional in Patients with COVID-19, Immunity, 54, 44, 10.1016/j.immuni.2020.12.002 · DOI · Paper page
  61. Schreibing, 2022, Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling, Front. Immunol., 13, 10.3389/fimmu.2022.1066176 · DOI
  62. Shomuradova, 2020, SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors, Immunity, 53, 1245, 10.1016/j.immuni.2020.11.004 · DOI · Paper page
  63. Gallien, 2015, Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM), Mol. Cell. Proteomics, 14, 1630, 10.1074/mcp.O114.043968 · DOI · Paper page
  64. Kent, 2002, The human genome browser at UCSC, Genome Res., 12, 996, 10.1101/gr.229102 · DOI · Paper page
  65. Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
  66. Fukushi, 2005, Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein, J. Gen. Virol., 86, 2269, 10.1099/vir.0.80955-0 · DOI · Paper page
  67. Lawson, 1995, Recombinant vesicular stomatitis viruses from DNA, Proc. Natl. Acad. Sci. USA, 92, 4477, 10.1073/pnas.92.10.4477 · DOI · Paper page

Cited by

Metadata

Authors
Arieta, C. M., Xie, Y. J., Rothenberg, D. A., Diao, H., Harjanto, D., Meda, S., Marquart, K., Koenitzer, B., Sciuto, T. E., Lobo, A., Zuiani, A., Krumm, S. A., Cadima Couto, C. I., Hein, S., Heinen, A. P., Ziegenhals, T., Liu-Lupo, Y., Vogel, A. B., Srouji, J. R., Fesser, S., Thanki, K., Walzer, K., Addona, T. A., Türeci, Ö., Şahin, U., Gaynor, R. B., & Poran, A.
Venue
Cell
Publisher
Elsevier BV
Published
2023-05
Volume
186
Issue
11
Pages
2392-2409.e21
ISSN
0092-8674
Cited by
91
References
50
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.